HSP-dependent protection against gastrointestinal diseases

Current Pharmaceutical Design

Volumn 16, Issue 10, 2010, Pages 1190-1196

  Mizushima, Tohru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Gastric ulcer; GGA; HSF1; HSP70; IBD; Lesions of the small intestine

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; TEPRENONE; TUMOR NECROSIS FACTOR ALPHA;

COLITIS; CROHN DISEASE; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; STOMACH ANTRUM PROLAPSE; STOMACH MUCOSA INJURY; STOMACH ULCER; ULCERATIVE COLITIS; ULCEROGENESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DITERPENES; DRUG EVALUATION, PRECLINICAL; GASTROINTESTINAL TRACT; HEAT-SHOCK PROTEINS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINE, SMALL; IRRITANTS; MICE; MICE, TRANSGENIC; PROTECTIVE AGENTS; STOMACH ULCER;

EID: 77950914949     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790945986     Document Type: Review

References (51)

1. Mathew A, Morimoto RI. Role of the heat-shock response in the life and death of proteins. Ann NY Acad Sci 1998; 851: 99-111. (Pubitemid 28370369)
2. Morimoto RI. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 1998; 12: 3788-3796
3. Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996; 111:345-357 (Pubitemid 26256722)
4. Katsuno M, Sang C, Adachi H, Minamiyama M, Waza M, Tanaka F, et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine- mediated motor neuron disease. Proc Natl Acad Sci USA 2005; 102: 16801-16806 (Pubitemid 41688857)
5. Tomisato W, Takahashi N, Komoto C, Rokutan K, Tsuchiya T, Mizushima T. Geranylgeranylacetone protects cultured guinea pig gastric mucosal cells from indomethacin. Dig Dis Sci 2000; 45:1674-1679 (Pubitemid 30133889)
6. Takano T, Tsutsumi S, Tomisato W, Hoshino T, Tsuchiya T, Mizushima T. Geranylgeranylacetone protects guinea pig gastric mucosal cells from gastric stressor-induced apoptosis. Dig Dis Sci 2002; 47: 1546-1553 (Pubitemid 34753935)
7. Tomisato W, Tsutsumi S, Tsuchiya T, Mizushima T. Geranylgeranylacetone protects guinea pig gastric mucosal cells from gastric stressor-induced necrosis by induction of heat-shock proteins. Biol Pharm Bull 2001; 24: 887-891 (Pubitemid 32750312)
8. Mizushima T, Tsutsumi S, Rokutan K, Tsuchiya T. Suppression of ethanol-induced apoptotic DNA fragmentation by geranylgeranylacetone in cultured guinea pig gastric mucosal cells. Dig Dis Sci 1999; 44: 510-514 (Pubitemid 29137959)
9. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998; 114: 823-839
10. Miller TA. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983; 245: G601-23.
11. Terano A, Hiraishi H, Ota S, Sugimoto T. Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 1986; 33: 206-210 (Pubitemid 16165699)
12. Ushijima H, Tanaka K, Takeda M, Katsu T, Mima S, Mizushima T. Geranylgeranylacetone protects membranes against nonsteroidal anti-inflammatory drugs. Mol Pharmacol 2005; 68: 1156-1161 (Pubitemid 41345808)
13. Tanaka K, Tsutsumi S, Arai Y, Hoshino T, Suzuki K, Takaki E, et al. Genetic evidence for a protective role of heat shock factor 1 against irritant-induced gastric lesions. Mol Pharmacol 2007; 71:985-993 (Pubitemid 46457003)
14. Suemasu S, Tanaka K, Namba T, Ishihara T, Katsu T, Fujimoto M, et al. A role of HSP70 in protecting against indomethacin-induced gastric lesions. J Biol Chem 2009; 284: 19705-19715
15. Ebert MP, Schafer C, Chen J, Hoffmann J, Gu P, Kubisch C, et al. Protective role of heat shock protein 27 in gastric mucosal injury. J Pathol 2005; 207: 177-184 (Pubitemid 41404148)
16. Cuzzocrea S. Emerging biotherapies for inflammatory bowel disease. Expert Opin Emerg Drugs 2003; 8: 339-347 (Pubitemid 37522655)
17. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429
18. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 2004; 50: 81-92. (Pubitemid 39286320)
19. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94: 174-181 (Pubitemid 23308385)
20. Danese S, Semeraro S, Marini M, Roberto I, Armuzzi A, Papa A, et al. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig Liver Dis 2005; 37: 811-818 (Pubitemid 44356115)
21. Ludwig D, Stahl M, Ibrahim ET, Wenzel BE, Drabicki D, Wecke A, et al. Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases. Dig Dis Sci 1999; 44:1440-1447 (Pubitemid 29404311)
22. Xie Y, Chen C, Stevenson MA, Auron PE, Calderwood SK. Heat shock factor 1 represses transcription of the IL-1 beta gene through physical interaction with the nuclear factor of interleukin 6. J Biol Chem 2002; 277: 11802-11810 (Pubitemid 34952735)
23. Singh-Jasuja H, Hilf N, Arnold-Schild D, Schild H. The role of heat shock proteins and their receptors in the activation of the immune system. Biol Chem 2001; 382: 629-636 (Pubitemid 32472173)
24. Tanaka K, Namba T, Arai Y, Fujimoto M, Adachi H, Sobue G, et al. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J Biol Chem 2007; 282: 23240-23252 (Pubitemid 47311960)
25. Ohkawara T, Nishihira J, Takeda H, Miyashita K, Kato K, Kato M, et al. Geranylgeranylacetone protects mice from dextran sulfate sodium-induced colitis. Scand J Gastroenterol 2005; 40: 1049-1057 (Pubitemid 41291354)
26. Ohkawara T, Nishihira J, Takeda H, Katsurada T, Kato K, Yoshiki T, et al. Protective effect of geranylgeranylacetone on trinitrobenzene sulfonic acid-induced colitis in mice. Int J Mol Med 2006; 17: 229-234
27. Sun D, Chen D, Du B, Pan J. Heat shock response inhibits NF-kappaB activation and cytokine production in murine Kupffer cells. J Surg Res 2005; 129: 114-121 (Pubitemid 41501863)
28. Guzhova IV, Darieva ZA, Melo AR, Margulis BA. Major stress protein Hsp70 interacts with NF-kB regulatory complex in human T-lymphoma cells. Cell Stress Chaperones 1997; 2: 132-139
29. Chan JY, Ou CC, Wang LL, Chan SH. Heat shock protein 70 confers cardiovascular protection during endotoxemia via inhibition of nuclear factor-kappaB activation and inducible nitric oxide synthase expression in the rostral ventrolateral medulla. Circulation 2004; 110: 3560-3566
30. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866
31. Chen H, Wu Y, Zhang Y, Jin L, Luo L, Xue B, et al. Hsp70 inhibits lipopolysaccaharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination. FEBS Lett 2006; 580: 3145-3152 (Pubitemid 43729683)
32. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68: 499-508. (Pubitemid 23171848)
33. Nakabe N, Kokura S, Shimozawa M, Katada K, Sakamoto N, Ishikawa T, et al. Hyperthermia attenuates TNF-alpha-induced up regulation of endothelial cell adhesion molecules in human arterial endothelial cells. Int J Hyperthermia 2007; 23: 217-224 (Pubitemid 46860591)
34. Maiden L, Thjodleifsson B, Seigal A, Bjarnason II, Scott D, Birgisson S, et al. Long-term effects of nonsteroidal antiinflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007; 5: 1040-1045
35. Lanas A, Ferrandez A. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention. Chin J Dig Dis 2006; 7: 127-133 (Pubitemid 43983743)
36. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005; 3: 55-59
37. Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 1991; 337:520.
38. Sigthorsson G, Simpson RJ, Walley M, Anthony A, Foster R, Hotz-Behoftsitz C, et al. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology 2002; 122: 1913-1923.
39. Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 2000; 14: 639-650 (Pubitemid 30240758)
40. Basivireddy J, Vasudevan A, Jacob M, Balasubramanian KA. Indomethacin-induced mitochondrial dysfunction and oxidative stress in villus enterocytes. Biochem Pharmacol 2002; 64: 339-349 (Pubitemid 34775312)
41. Wallace JL. The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage - potential for development of gastrointestinal tract safe NSAIDs. Can J Physiol Pharmacol 1994; 72: 1493-1498
42. Konaka A, Kato S, Tanaka A, Kunikata T, Korolkiewicz R, Takeuchi K. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Pharmacol Res 1999; 40: 517-524
43. Whittle BJ, Laszlo F, Evans SM, Moncada S. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 1995; 116: 2286-2290
44. Jacob M, Foster R, Sigthorsson G, Simpson R, Bjarnason I. Role of bile in pathogenesis of indomethacin-induced enteropathy. Arch Toxicol 2007; 81: 291-298
45. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Aisenberg J, Bhadra P, et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007; 25: 1211-1222
46. Aabakken L, Bjornbeth BA, Weberg R, Viksmoen L, Larsen S, Osnes M. NSAID-associated gastroduodenal damage: does famotidine protection extend into the mid- and distal duodenum? Aliment Pharmacol Ther 1990; 4: 295-303.
47. Urayama S, Musch MW, Retsky J, Madonna MB, Straus D, Chang EB. Dexamethasone protection of rat intestinal epithelial cells against oxidant injury is mediated by induction of heat shock protein 72. J Clin Invest 1998; 102: 1860-1865
48. Asano T, Tanaka K, Yamakawa N, Adachi H, Sobue G, Goto H, et al. Hsp 70 confers protection against indomethacin-induced lesions of the small intestine. J Pharmacol Exp Ther 2009; 330: 458-467
49. Corcoran BM, Stanton C, Fitzgerald G, Ross RP. Life under stress: the probiotic stress response and how it may be manipulated. Curr Pharm Des 2008; 14(14): 1382-1399 (Pubitemid 351982546)
50. Lomax AR, Calder PC. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des 2009; 15(13): 1428-1518
51. Stanford J, Stanford C, Stansby G, Bottasso O, Bahr G, Grange J. The common mycobacterial antigens and their importance in the treatment of disease. Curr Pharm Des 2009; 15(11): 1248-1260